These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3815119)

  • 1. Neurotoxic effects of methamphetamine assessed in three-dimensional reaggregate tissue cultures.
    Kontur PJ; Hoffmann PC; Heller A
    Brain Res; 1987 Jan; 428(1):7-14. PubMed ID: 3815119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and morphological studies on GABA neurons in reaggregate culture.
    Shalaby IA; Won L; Wainer B
    Brain Res; 1987 Jan; 402(1):68-77. PubMed ID: 3828789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of dopamine from mesencephalic neurons in aggregate cultures: influence of target and non-target cells.
    Shalaby IA; Hoffmann PC; Heller A
    Brain Res; 1984 Jul; 307(1-2):347-50. PubMed ID: 6467004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced dopamine cell survival in reaggregates containing telencephalic target cells.
    Hoffmann PC; Hemmendinger LM; Kotake C; Heller A
    Brain Res; 1983 Sep; 274(2):275-81. PubMed ID: 6626955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and persistent effects of methamphetamine on developing monoaminergic neurons in reaggregate tissue culture.
    Won L; Kontur PJ; Choi HK; Hoffmann PC; Heller B; Heller A
    Brain Res; 1992 Mar; 575(1):6-12. PubMed ID: 1504781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of developing dopaminergic neurons in reaggregate tissue culture following treatment with methamphetamine.
    Kontur PJ; Won LA; Hoffmann PC; Heller A
    Neurosci Lett; 1991 Aug; 129(2):254-8. PubMed ID: 1684029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal exposure to methamphetamine in utero stimulates development of serotonergic neurons in three-dimensional reaggregate tissue culture.
    Won L; Bubula N; Heller A
    Synapse; 2002 Feb; 43(2):139-44. PubMed ID: 11754494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine-induced decrease in neural glucocorticoid receptors: relationship to monoamine levels.
    Lowy MT; Novotney S
    Brain Res; 1994 Feb; 638(1-2):175-81. PubMed ID: 8199858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 2-deoxy-D-glucose on methamphetamine-induced dopamine and serotonin neurotoxicity.
    Callahan B; Yuan J; Stover G; Hatzidimitriou G; Ricaurte G
    J Neurochem; 1998 Jan; 70(1):190-7. PubMed ID: 9422362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of dopamine from coaggregate cultures of mesencephalic tegmentum and corpus striatum.
    Shalaby IA; Kotake C; Hoffmann PC; Heller A
    J Neurosci; 1983 Aug; 3(8):1565-71. PubMed ID: 6192230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
    Cass WA; Smith MP; Peters LE
    Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of chronic alcohol administration on changes of extracellular dopamine and serotonin concentration induced by methamphetamine--comparison of two different alcohol preference rat lines].
    Nishiguchi M; Kinoshita H; Taniguchi T; Utsumi T; Ouchi H; Minami T; Hishida S
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2002 Dec; 37(6):555-76. PubMed ID: 12607944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of striatal glutamatergic/GABAergic homeostasis following acute methamphetamine in mice.
    Pereira FC; Cunha-Oliveira T; Viana SD; Travassos AS; Nunes S; Silva C; Prediger RD; Rego AC; Ali SF; Ribeiro CA
    Neurotoxicol Teratol; 2012; 34(5):522-9. PubMed ID: 22884891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant-induced alterations in dopaminergic and serotonergic function in fetal raphe neurons.
    Bennett BA; Paris JM; Pecora JR
    Brain Res Bull; 1993; 31(5):471-6. PubMed ID: 8098652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parity decreases methamphetamine-induced striatal dopaminergic perturbation.
    Dluzen DE
    Neurochem Int; 2011 Aug; 59(2):101-3. PubMed ID: 21693145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin facilitates methamphetamine-induced dopamine overflow in rat striatum and fetal ventral mesencephalic grafts.
    Wang Y; Perng SL; Lin JC; Tsao WL
    Exp Neurol; 1994 Dec; 130(2):279-87. PubMed ID: 7867757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis.
    Nishijima K; Kashiwa A; Hashimoto A; Iwama H; Umino A; Nishikawa T
    Synapse; 1996 Apr; 22(4):304-12. PubMed ID: 8867025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective association of dopamine axons with their striatal target cells in vitro.
    Won L; Heller A; Hoffmann PC
    Brain Res Dev Brain Res; 1989 May; 47(1):93-100. PubMed ID: 2736769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity.
    Kuhn DM; Francescutti-Verbeem DM; Thomas DM
    Ann N Y Acad Sci; 2008 Oct; 1139():118-26. PubMed ID: 18991856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine self-administration and the effect of contingency on monoamine and metabolite tissue levels in the rat.
    Brennan KA; Colussi-Mas J; Carati C; Lea RA; Fitzmaurice PS; Schenk S
    Brain Res; 2010 Mar; 1317():137-46. PubMed ID: 19962371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.